Wealth Enhancement Advisory Services LLC Boosts Stock Position in Intuitive Surgical, Inc. $ISRG

Key Points

• Wealth Enhancement Advisory Services LLC increased its stake in Intuitive Surgical by 5.2% in Q2, owning 131,807 shares valued at approximately $71.77 million.
• Intuitive Surgical reported earnings of $2.19 per share for the last quarter, exceeding analyst expectations of $1.93, with revenue up 21.4% year-over-year.
• Institutional investors currently hold 83.64% of Intuitive Surgical's stock, indicating strong institutional confidence in the company.

Wealth Enhancement Advisory Services LLC lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 131,807 shares of the medical equipment provider's stock after acquiring an additional 6,508 shares during the quarter. Wealth Enhancement Advisory Services LLC's holdings in Intuitive Surgical were worth $71,765,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of Intuitive Surgical by 1.4% during the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider's stock valued at $16,178,258,000 after purchasing an additional 453,335 shares in the last quarter. Invesco Ltd. grew its stake in Intuitive Surgical by 1.7% in the first quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider's stock valued at $2,090,027,000 after acquiring an additional 71,794 shares during the period. Northern Trust Corp grew its position in shares of Intuitive Surgical by 0.3% in the first quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider's stock valued at $1,798,465,000 after purchasing an additional 11,988 shares in the last quarter. Wellington Management Group LLP lifted its stake in shares of Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider's stock valued at $1,732,975,000 after acquiring an additional 457,080 shares during the last quarter. Finally, Nuveen LLC purchased a new stake in Intuitive Surgical during the 1st quarter valued at $1,715,899,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock traded up $3.88 on Monday, reaching $442.60. 751,045 shares of the company's stock were exchanged, compared to its average volume of 2,038,224. The firm's 50-day moving average is $476.64 and its two-hundred day moving average is $503.43. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The company has a market capitalization of $158.66 billion, a P/E ratio of 61.71, a price-to-earnings-growth ratio of 4.60 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm's revenue was up 21.4% compared to the same quarter last year. During the same quarter last year, the company earned $1.78 EPS. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of the firm's stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the transaction, the director owned 739 shares of the company's stock, valued at $325,669.91. This trade represents a 31.19% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares of the company's stock, valued at $9,368,059.23. This trade represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 45,224 shares of company stock worth $21,716,492. Corporate insiders own 0.70% of the company's stock.

Analyst Ratings Changes

A number of research firms have weighed in on ISRG. Truist Financial upped their target price on Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a report on Wednesday, July 23rd. BTIG Research increased their target price on shares of Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reissued a "sell" rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Evercore ISI boosted their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research report on Tuesday, July 8th. Finally, Erste Group Bank restated a "hold" rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Thirteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average price target of $595.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.